ADALAT

Main information

  • Trade name:
  • ADALAT 20 mg prolonged-release tablet
  • Dosage:
  • 20 mg
  • Pharmaceutical form:
  • prolonged-release tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ADALAT 20 mg prolonged-release tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Nifedipine
  • Product summary:
  • Suitability for use in older adult patients Nifedipinum Suitable for older persons (long-acting preparations). Do not use short-acting preparations. Significant adverse effects include ankle oedema and orthostatic hypotension. Take interactions into account. Avoid consuming grapefruit juice during treatment.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8624
  • Authorization date:
  • 23-01-2009
  • Last update:
  • 26-07-2018